(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of 3.52% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 20.41%.
Assertio Holdings's revenue in 2025 is $125,763,000.On average, 2 Wall Street analysts forecast ASRT's revenue for 2025 to be $12,429,777,393, with the lowest ASRT revenue forecast at $12,332,867,426, and the highest ASRT revenue forecast at $12,526,687,360.
In 2026, ASRT is forecast to generate $13,720,159,860 in revenue, with the lowest revenue forecast at $13,720,159,860 and the highest revenue forecast at $13,720,159,860.